July 25, 2019 – Wolters Kluwer, Health announced today it has partnered with the Chinese Medical Association (CMA) to launch Maternal-Fetal Medicine (MFM), an open access journal focused on the field of obstetrics and maternal-fetal medicine. The new journal will publish high-quality scientific articles related to such topics as medical complications and adverse effects of pregnancy, fetal development, prenatal screening and diagnosis, fetal treatment and therapy, and technology and developments in obstetrics and maternal-fetal medicine
MFM articles will include original clinical and translational research, state-of-the-art reviews, commentaries, case studies and reports, and letters to the editor. The journal will be available in print and online and will reach into a growing market in China, where the CMA has 88 specialty societies and 677,000 members.
“We are delighted to be working with the Chinese Medical Association on the creation of this new journal,” said Jayne Marks, Vice President, Global Publishing, Wolters Kluwer, Health Learning, Research and Practice. “As a global company, Wolters Kluwer’s goal is to bring important research to the healthcare field worldwide to help ensure that patients are getting the best care. The launch of Maternal-Fetal Medicine advances that goal.”
MFM is the fourth open access journal published by Wolters Kluwer and CMA. Also included in the CMA portfolio are Chinese Medical Journal, Journal of Bio-X Research and Journal of Pancreatology.
“We are proud to extend our relationship with Wolters Kluwer with the publication of Maternal-Fetal Medicine,” said Yongmao Jiang, Deputy Secretory, Director of Periodicals Administrative Department, Chinese Medical Association. “This new journal will serve as a platform for free and timely scholarly exchanges about maternal-fetal medicine. It will be an invaluable resource for physicians, nurses, researchers, students and anyone involved in the field of obstetrics and gynecology in China and around the world.”
MFM launches on July 25, 2019. To read more about the journal, please visit www.maternal-fetalmedicine.org.
Manuscripts may be submitted at https://www.editorialmanager.com/mfm.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global provider of professional information, software solutions, and services for physicians, nurses, accountants, lawyers, tax specialists, and finance, audit, compliance, and regulatory sectors.
The company provides expert solutions - a combination of deep domain knowledge with specialized technology and services - that help professionals navigate change, solve complex problems, and deliver impact in their respective fields.
Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer holds market-leading positions in 40 countries globally, represents customers across 180 countries and employs 18,600 people worldwide. In 2018, it reported annual revenues of €4.3 billion.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.